logo
Annual Fight For Air Climb at Soldier Field raises over $350K for lung health

Annual Fight For Air Climb at Soldier Field raises over $350K for lung health

CBS News5 hours ago

Despite the heat in Chicago, climbers took to Soldier Field for the annual Fight For Air Climb event to raise thousands of dollars for lung health.
Over 700 people from different skill levels participated in Sunday morning's event, presented by UnitedHealthcare, to raise money for research, education, and advocacy. In the end, they raised over $350,000.
The climb helps support the over 1.4 million people living with lung disease in Illinois.
Due to the weekend's dangerous weather, organizers had changed the original 1,600-step route and added portable misting fans. The heat, however, didn't stop the Firefighter Challenge as teams of firefighters climbed in full gear.
The American Lung Association said it looks forward to next year's event and "continuing its commitment to improving lung health and preventing lung disease."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New Data Show Delve Bio's Metagenomic Testing Delivers Broader, Deeper Pathogen Identification Compared to Traditional Testing
New Data Show Delve Bio's Metagenomic Testing Delivers Broader, Deeper Pathogen Identification Compared to Traditional Testing

Yahoo

time44 minutes ago

  • Yahoo

New Data Show Delve Bio's Metagenomic Testing Delivers Broader, Deeper Pathogen Identification Compared to Traditional Testing

Data Presented at the 2025 American Society for Microbiology Microbe Conference BOSTON, June 22, 2025--(BUSINESS WIRE)--Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data presented at the American Society for Microbiology (ASM) Microbe conference in Los Angeles showing the impact of metagenomic sequencing for transforming infectious disease diagnostics by offering advances compared to traditional microbiological testing. Among the data presented at the meeting is a comparison of Delve's metagenomic cerebrospinal fluid (CSF) test, Delve Detect CSF, compared to a traditional PCR-based meningitis/encephalitis (ME) panel. The study reanalyzed samples from a diverse patient cohort previously tested using the ME panel. The data showed that mNGS can be used in conjunction with microbiological testing to increase diagnostic yield by identifying pathogens that are not detectable with traditional, pathogen-specific panel testing. The inclusion of mNGS tests like Delve Detect, which has a 48-hour turnaround time, can shorten time to diagnosis, enabling clinicians to initiate targeted therapies sooner. "This study showed substantial agreement between Delve Detect and a syndromic PCR panel. But importantly, Delve Detect also identified pathogens that were not included on the PCR panel and would have been missed as causes of a patient's infection if mNGS were not included in the diagnostic workup," said Benjamin Bradley, M.D., Ph.D., medical director of virology and molecular infectious diseases at ARUP Laboratories. "This study supports including mNGS in the diagnostic workup for patients with complex central nervous system infections." The study included 122 samples — 47 positive and 75 negative. Analysis showed that in comparison with the ME panel, Delve Detect CSF demonstrated approximately 10% higher positivity rate (48% vs. 38%), with an additive diagnostic yield of 24%. This added yield included detection of multiple co-infections, 16 unique organisms not included in the ME panel, and positive detections in 19 samples (25%) that were negative by the ME panel. Additionally, in samples that were negative by both tests, Delve Detect CSF showed high agreement (95%) with the ME panel, supporting the negative predictive value of mNGS. The company's full presence at ASM Microbe 2025 includes: Delve's chief medical officer Steve Miller, M.D., Ph.D. hosted A New Era: Metagenomic Sequencing for Comprehensive Pathogen Detection, exploring real world evidence, clinical cases and considerations for laboratory teams implementing mNGS. Presentation of a case report in a feature poster, Using Metagenomic Sequencing to Diagnose a Novel Moraxella CNS Shunt Infection in a Culture-Negative Case Presentation of data comparing the company's mNGS CSF test, Delve Detect, to a widely used, PCR meningitis/encephalitis panel as part of the session Assessing the Clinical Impact of Next-Generation Sequencing: Where Are We Now? "These presentations at ASM highlight the transformation underway in infectious disease diagnostics. Delve Bio's metagenomic sequencing technology enables clinicians to identify the cause of serious central nervous system infections when existing methods do not deliver a diagnosis and speed is critical," said Brad Murray, chief executive officer of Delve Bio. "We're working to make this technology more widely available to neurologists, infectious disease physicians and laboratory teams so they can get patients the answers they need." Conference attendees are also invited to visit Delve Bio at booth #1440 to learn more about the company's metagenomic platform, including Delve Detect and its proprietary bioinformatics platform Delve Decide. Delve Detect is Delve Bio's flagship metagenomic testing service, providing comprehensive pathogen detection with a 48-hour turnaround time after sample receipt and including access to Delve's Clinical Microbial Sequencing Board, an on-call team of infectious disease experts who review results in clinical context. About Delve Bio, Inc. Delve Bio is a metagenomic next-generation sequencing (mNGS) company that empowers laboratories and clinicians with the insights they need to confidently diagnose routine and rare infectious diseases, thereby minimizing the impact of harmful pathogens on humanity. By leveraging its unbiased, pathogen-agnostic mNGS platform, Delve Bio is able to identify a wide range of pathogens with a single test. Founded by world leaders in genomics and infectious disease Drs. Charles Chiu, Joe DeRisi, Michael Wilson, Pardis Sabeti, and Matthew Meyerson, the company is backed by top institutional investors including Perceptive Xontogeny Venture Fund II, Section 32, and GV, along with leading individual investors. For more information, visit View source version on Contacts Company Contact Amy WongSenior Director of Marketing and Business Development, Delve BioEmail: media@ Media Contact Julie McKeough42 North for Delve BioEmail: julie@ Sign in to access your portfolio

Hall of Famer D. Wayne Lukas has been hospitalized and will not return to training, family says
Hall of Famer D. Wayne Lukas has been hospitalized and will not return to training, family says

Washington Post

time2 hours ago

  • Washington Post

Hall of Famer D. Wayne Lukas has been hospitalized and will not return to training, family says

LOUISVILLE, Ky. — Hall of Fame horse racing trainer D. Wayne Lukas has been hospitalized and will not return to training, Churchill Downs announced Sunday after speaking with members of his family. Lukas' family said the 89-year-old has battled a severe infection that has worsened and that he has declined an aggressive treatment plan to instead return home. His horses have been transferred to assistant trainer Sebastian 'Bas' Nicholl.

These tips can help keep people stay cool and healthy during a heat wave
These tips can help keep people stay cool and healthy during a heat wave

CBS News

time2 hours ago

  • CBS News

These tips can help keep people stay cool and healthy during a heat wave

Here are tips for beating the heat in Southeast Michigan Here are tips for beating the heat in Southeast Michigan Here are tips for beating the heat in Southeast Michigan The first day of summer officially was Friday, and on Saturday, people in Michigan felt it. Metro Detroit, much like the rest of the country, began to experience the season's first heat wave, and families across the region made their way to wherever they could cool off, like at Heritage Park in Farmington Hills. "My kids all week were like, 'We really want water, mom,' and we couldn't wait for today because it was so hot outside," Jenna Megalizzi, who is visiting from Pennsylvania, said. "So, we kind of scoured the area and figured this was a good place to water is always welcome during the summer heat." While the splash pad was busy all day Saturday, it should look like more of the same as the weather stays uncomfortably hot. Experts say heat like this could be dangerous. "When you have heat exhaustion, when you have high temperatures, you are also putting your body through a dehydration kind of strike," Dr. Chadi Alraies, a cardiologist at Detroit Medical Center, said. Alraies added that, similar to when we experience the extreme cold, he expects the emergency room to be busier than normal during this heat wave. "The squeeze function of the heart will go up, the exertion that the heart has to go through goes up, the blood pressure goes up, which also puts stress on the heart," Alraies said. He suggests people limit their time in the sun, especially from 12 p.m. to 4 p.m., and always stay hydrated by drinking water with electrolytes. Parents at the splashpad said they're emphasizing that same advice to their kids. Cousins Eve and Treasure told me their plans to stay cool, "Probably in the air conditioning once we get home. Yeah, a lot of water and sunscreen too. Staying hydrated, too," Cousins Eve and Treasure said. Another important note for times like this is that the heat is most dangerous for the very young and very old.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store